BFK — Pharmesis International Balance Sheet
0.000.00%
Last trade - 00:00
- SG$19.65m
- SG$22.52m
- CNY45.64m
- 22
- 19
- 94
- 39
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 14.7 | 15.2 | 14 | 19.7 | 9.48 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 17.1 | 12.7 | 14.2 | 12.9 | 8.31 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 38.9 | 37 | 37.1 | 44.2 | 33.3 |
Net Property, Plant And Equipment | 53.7 | 51.8 | 53.1 | 51.3 | 50.2 |
Net Goodwill | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 93.9 | 91.3 | 92.7 | 97.9 | 85.9 |
Accounts Payable | |||||
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 29.2 | 32.4 | 30.8 | 39.6 | 30.6 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Liabilities | 31.8 | 35 | 35.2 | 44 | 34.8 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 62.1 | 56.3 | 57.5 | 53.9 | 51.1 |
Total Liabilities & Shareholders' Equity | 93.9 | 91.3 | 92.7 | 97.9 | 85.9 |
Total Common Shares Outstanding |